Make VIZZ samples and product available in the United States
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 31 Jul 2025
- Due
- 31 Oct 2025
- Delivered
- October 2025
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“VIZZ samples and product availability in the United States expected as early as October 2025”
What we found
Evidence strength A What the grades mean
The company initiated professional product sample distribution and commercial product shipments in October 2025, meeting the commitment for availability as early as October 2025.
-
A LENZ Therapeutics, Inc. 10-K filed 2026-03-24
“Professional product sample distribution by the sales force to optometrists and ophthalmologists and commercial product shipments to customers via our e-pharmacy partner were initiated in October 2025” ✓ confirmed on the page
Market reaction: the shares moved -17.2% against the S&P 500 over the three sessions around the disclosure (23 Mar 2026 to 26 Mar 2026). What this measures
Checked 2 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Product other
- Indicative materiality
- Low rules
- Action
- Make
- Deliverable
- VIZZ samples and product
- Where
- United States
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- Medium
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you LENZ Therapeutics, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2025-LENZ-003369 · Corrections policy